Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference
Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced that management will attend the 43rd Annual J.P. Morgan Healthcare Conference. If you are interested in a meeting ...
AFP30m
Aiosyn Mitosis Breast Becomes the First AI-Powered Mitosis Detection Solution to Achieve CE Mark Certification Under IVDR
Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its ...